Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,540 | -9,297 | -6,911 | -3,951 | -2,013 |
| Depreciation Amortization | 160 | 306 | 237 | 151 | 68 |
| Accounts payable and accrued liabilities | -315 | 299 | -81 | -100 | 421 |
| Other Working Capital | -774 | 579 | 1,320 | 32 | -58 |
| Other Operating Activity | 534 | 372 | 637 | 332 | -295 |
| Operating Cash Flow | $-2,934 | $-7,742 | $-4,797 | $-3,536 | $-1,877 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -341 | -1,199 | -961 | -170 | -46 |
| Investing Cash Flow | $-341 | $-1,199 | $-961 | $-170 | $-46 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1 | -1 | N/A | 0 | N/A |
| Common Stock Issued | N/A | 29 | N/A | N/A | N/A |
| Other Financing Activity | -58 | -20 | 0 | 0 | 0 |
| Financing Cash Flow | $-59 | $8 | $N/A | $0 | $N/A |
| Beginning Cash Position | 10,115 | 19,048 | 19,048 | 19,048 | 19,048 |
| End Cash Position | 6,782 | 10,115 | 13,289 | 15,342 | 17,124 |
| Net Cash Flow | $-3,333 | $-8,933 | $-5,758 | $-3,706 | $-1,924 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,934 | -7,742 | -4,797 | -3,536 | -1,877 |
| Capital Expenditure | -341 | -1,199 | -961 | -170 | -46 |
| Free Cash Flow | -3,274 | -8,941 | -5,759 | -3,706 | -1,924 |